Alpha 7 nicotinic acetylcholine receptor expression and activity during neuronal differentiation of PC12 pheochromocytoma cells.
Nicotinic acetylcholine receptors (nAChR) exert pivotal roles in synaptic transmission, neuroprotection and differentiation. Particularly, homomeric alpha7 receptors participate in neurite outgrowth, presynaptic control of neurotransmitter release and Ca2+ influx. However, the study of recombinant alpha7 nAChRs in transfected cell lines is difficult due to low expression of functional receptor channels. We show that PC12 pheochromocytoma cells induced to differentiation into neurons are an adequate model for studying differential nAChR gene expression and receptor activity. Whole-cell current recording indicated that receptor responses increased during the course of differentiation. Transcription of mRNAs coding for alpha3, alpha5, alpha7, beta2 and beta4 subunits was present during the course of differentiation, while mRNAs coding for alpha2, alpha4 and beta3 subunits were not expressed in PC12 cells. alpha7 subunit expression was highest following 1 day of induction to differentiation. Activity of alpha7 nAChRs, however, was most elevated on day 2 as revealed by inhibition experiments in the presence of 10 nM methyllycaconitine, rapid current decay and receptor responsiveness to the alpha7 agonist choline. Increased alpha7 receptor activity was noted when PC12 were induced to differentiation in the presence of choline, confirming that chronic agonist treatment augments nAChR activity. In summary, PC12 cells are an adequate model to study the role and pharmacological properties of this receptor during neuronal differentiation.
Nery
Arthur A
AA
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Resende
Rodrigo R
RR
Martins
Antonio H
AH
Trujillo
Cleber A
CA
Eterovic
Vesna A
VA
Ulrich
Henning
H
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics*; D018507:Gene Expression Regulation, Developmental / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D016716:PC12 Cells; D010673:Pheochromocytoma / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D011978:Receptors, Nicotinic / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics*; D064569:alpha7 Nicotinic Acetylcholine Receptor
C579165:Chrna7 protein, rat; D011978:Receptors, Nicotinic; D064569:alpha7 Nicotinic Acetylcholine Receptor
J Neurosci. 2005 Jun 8;25(23):5563-72
15944384
Nature. 1975 Nov 27;258(5533):341-2
1196362
Annu Rev Physiol. 1995;57:521-46
7778876
Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8
1065897
J Neurosci. 2005 Apr 6;25(14):3712-23
15814802
Neurosci Lett. 1994 Aug 1;176(2):152-6
7830936
Mol Pharmacol. 2007 Sep;72(3):715-24
17565004
Br J Pharmacol. 2005 Dec;146(8):1087-95
16230999
Biophys J. 2005 Jun;88(6):3954-65
15805177
J Pharmacol Exp Ther. 2003 Jun;305(3):1132-41
12626641
J Neurosci. 1987 Nov;7(11):3639-53
3316527
J Neurosci. 1995 Mar;15(3 Pt 1):1912-39
7891142
Neuron. 1996 Jun;16(6):1077-85
8663984
J Neurochem. 1996 Aug;67(2):530-9
8764577
Brain Res Dev Brain Res. 2002 Dec 15;139(2):175-87
12480132
Dev Biol. 1988 Sep;129(1):1-11
2457524
Biophys J. 1987 Nov;52(5):873-83
2447965
J Cell Biol. 1986 Mar;102(3):821-9
3005337
Biochemistry. 2007 Jun 5;46(22):6628-38
17497892
J Neurosci. 2003 Jun 1;23(11):4590-600
12805299
J Biol Chem. 2005 Sep 2;280(35):31085-90
15987688
Biotechniques. 2001 Dec;31(6):1382-6, 1388
11768668
Br J Pharmacol. 2009 Feb;156(4):638-48
19226255
Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):1-7
15469877
J Pharmacol Exp Ther. 2005 Apr;313(1):24-35
15590768
Biochem Pharmacol. 2007 Oct 15;74(8):1112-9
17603025
Curr Opin Pharmacol. 2005 Feb;5(1):53-9
15661626
Trends Pharmacol Sci. 2002 Mar;23(3):130-6
11879680
J Neurochem. 2007 Apr;101(1):160-7
17241116
Mol Pharmacol. 2003 Oct;64(4):974-86
14500754
J Neurosci Res. 2008 Jan;86(1):93-107
17868151
FEBS J. 2007 Aug;274(15):3799-845
17651090
Cell Calcium. 2008 Feb;43(2):107-21
17662384
J Physiol Paris. 2006 Mar-May;99(2-3):162-71
16458492
J Cell Physiol. 1992 Mar;150(3):647-56
1311333
Eur J Pharmacol. 2000 Mar 30;393(1-3):59-67
10770998
Brain Res Dev Brain Res. 2003 May 14;142(2):151-60
12711366
J Biol Chem. 2004 Apr 30;279(18):18767-75
14764595
Eur J Neurosci. 1995 Feb 1;7(2):251-60
7757262
J Neurosci. 2002 Jan 1;22(1):29-37
11756485
Eur J Neurosci. 1997 Dec;9(12):2734-42
9517478
Prog Neurobiol. 1997 Oct;53(2):199-237
9364611
Exp Cell Res. 2008 Apr 15;314(7):1429-43
18331729
Cytometry A. 2009 Jan;75(1):38-53
18988295
Nature. 1990 Apr 5;344(6266):544-7
2320126
J Neurosci. 1993 Feb;13(2):596-604
7678857
Mol Hum Reprod. 2005 Dec;11(12):881-9
16421212